Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
721 Results Found
CDC drops mask requirement in health care settings
The Centers for Disease Control and Prevention (CDC) last week released guidance dropping its requirement for
CDC Updates COVID-19 Guidance for Health Care Providers
The Centers for Disease Control and Prevention Friday, Sept. 23 released updates to certain COVID-19 guidance pertaining to health care providers.
AHA Urges HHS to Extend Public Health Emergency Beyond October
AHA urges HHS to renew the COVID-19 public health emergency due to expire in October.
HHS: Hospital COVID-19 Data Reporting will Transition to CDC This December
The Department of Health and Human Services (HHS) has announced that the Centers for Disease Control and Prevention (CDC) will assume responsibility for the collection of hospital COVID-19 data, beginning in mid-December 2022.
White House: Public will need annual COVID boosters
White House health leaders stated this week the public likely will need annual COVID-19 booster shots,
FDA approves fall boosters
The Food and Drug Administration (FDA) this week approved COVID-19 booster shots from Pfizer and Moderna targeting the omicron BA.4 and BA.5 subvariants
CDC to take back control of COVID-19 hospital data collection
The Centers for Disease Control and Prevention (CDC) will resume control of COVID-19 hospital data collection in mid-December
FDA recommends repeating COVID-19 at-home test in 48 hours if negative
The Food and Drug Administration yesterday advised people who get a negative result from an at-home COVID-19 antigen test to test themselves again after 48 hours to reduce the risk of missing an infection and spreading the virus to others.
CDC updates public health guidance for preventing COVID-19 illness
The CDC released updated guidance to help people protect themselves and others if they are exposed to, sick or test positive for COVID-19.
FDA grants full approval to Pfizer’s COVID-19 vaccine for 12-15 age group
The FDA granted full approval of Pfizer’s COVID-19 vaccine for young teens, covering the age group spanning 12 to 15 years old